Lexeo Therapeutics (LXEO) Non-cash Items (2022 - 2026)

Lexeo Therapeutics' Non-cash Items history runs 5 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 493.63% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 493.63% YoY), while the FY2025 annual figure was $2.6 million, up 30.78% from the prior year.
• Non-cash Items came in at $2.8 million for Q1 2026 at Lexeo Therapeutics, down from $11.3 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $20.1 million in Q4 2022 to a low of $475000.0 in Q1 2025.
• A 5-year average of $8.7 million and a median of $7.3 million in 2023 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items plunged 97.4% in 2025 and jumped 493.63% in 2026, its largest moves.
• Lexeo Therapeutics' Non-cash Items stood at $20.1 million in 2022, then sank by 32.0% to $13.7 million in 2023, then sank by 79.17% to $2.9 million in 2024, then soared by 296.49% to $11.3 million in 2025, then slumped by 75.06% to $2.8 million in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $2.8 million, $11.3 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison